Archives

Utilizing Multidimensional Immune Modeling to Advance Precision Medicine By David Messina, PhD Today, it’s hard to predict which patients will respond to a therapy. Disease, particularly cancers, [...]

Steven Daniel joins Cofactor Genomics as Vice President of Business Development — Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San [...]

Past to Present: Cofactor Beginnings and Where We Are Today Fatima is the Comptroller at Cofactor Genomics, and has had the advantage of starting when the company began. She shares a unique [...]

More Precise Treatment Decisions Rely on Better Biomarkers This week’s Q&A features Eric Duncavage, MD, the Medical Director at Cofactor Genomics. He is a Board Certified Clinical Diagnostic [...]

Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery — Contributing to both the Cancer and [...]

Supporting the Future of Precision Medicine It’s already June, a time when everyone else is welcoming summer, but in San Francisco, we’re bracing for the fog and chilly weather. This week we’re [...]